Fetal inhibition of inflammation improves disease phenotypes in harlequin ichthyosis

Human Molecular Genetics

Volumn 24, Issue 2, 2015, Pages 436-449

  Cottle, Denny L ^a   Ursino, Gloria M A ^a   Ip, Sally Chi Ieng ^a   Jones, Lynelle K ^a   Ditommaso, Tia ^a   Hacking, Douglas F ^c,g   Mangan, Niamh E ^d   Mellett, Natalie A ^e   Henley, Katya J ^b   Sviridov, Dmitri ^e   Nold Petry, Claudia A ^d   Nold, Marcel F ^d   Meikle, Peter J ^e   Kile, Benjamin T ^b,f   Smyth, Ian M ^a  

^a MONASH UNIVERSITY   (Australia)

^b WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^f UNIVERSITY OF MELBOURNE   (Australia)

^g ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; INTERLEUKIN 37B; LIPID; UNCLASSIFIED DRUG; IL37 PROTEIN, MOUSE; INTERLEUKIN 1;

ABCA12 GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; EMBRYO; EPIDERMIS; FETUS; GENE; GENE OVEREXPRESSION; HARLEQUIN ICHTHYYOSIS; ICHTHYOSIS; INFLAMMATION; KERATINOCYTE; LIPID METABOLISM; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SKIN DISEASE; TRANSGENE; ANIMAL; CYTOLOGY; DISEASE MODEL; EMBRYOLOGY; FEMALE; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; LAMELLAR ICHTHYOSIS; MALE; PATHOPHYSIOLOGY; SKIN;

ANIMALS; CELL DIFFERENTIATION; CHEMOKINES; DISEASE MODELS, ANIMAL; EPIDERMIS; FEMALE; HUMANS; ICHTHYOSIS, LAMELLAR; INTERLEUKIN-1; KERATINOCYTES; MALE; MICE; MICE, KNOCKOUT; PHENOTYPE; SKIN;

EID: 84922424772     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddu459     Document Type: Article

References (52)

1. Akiyama, M. and Shimizu, H. (2008) An update on molecular aspects of the non-syndromic ichthyoses. Exp. Dermatol., 17, 373-382.
2. Akiyama, M., Sugiyama-Nakagiri, Y., Sakai, K., McMillan, J.R., Goto, M., Arita, K., Tsuji-Abe, Y., Tabata, N., Matsuoka, K., Sasaki, R. et al. (2005) Mutations in lipid transporter ABCA12 in harlequin ichthyosis and functional recovery by corrective gene transfer. J. Clin. Invest., 115, 1777-1784.
3. Kelsell, D.P., Norgett, E.E., Unsworth, H., Teh, M.T., Cullup, T., Mein, C.A., Dopping-Hepenstal, P.J., Dale, B.A., Tadini, G., Fleckman, P. et al. (2005) Mutations in ABCA12 underlie the severe congenital skin disease harlequin ichthyosis. Am. J. Hum. Genet., 76, 794-803.
4. Smyth, I., Hacking, D.F., Hilton, A.A., Mukhamedova, N., Meikle, P.J., Ellis, S., Satterley, K., Collinge, J.E., de Graaf, C.A., Bahlo, M. et al. (2008) A mouse model of harlequin ichthyosis delineates a key role for Abca12 in lipid homeostasis. PLoS Genet., 4, e1000192.
5. Yanagi, T., Akiyama, M., Nishihara, H., Sakai, K., Nishie, W., Tanaka, S. and Shimizu, H. (2008) Harlequin ichthyosis model mouse reveals alveolar collapse and severe fetal skin barrier defects. Hum. Mol. Genet., 17, 3075-3083.
6. Zuo, Y., Zhuang, D.Z., Han, R., Isaac, G., Tobin, J.J., McKee, M., Welti, R., Brissette, J.L., Fitzgerald, M.L. and Freeman, M.W. (2008) ABCA12 maintains the epidermal lipid permeability barrier by facilitating formation of ceramide linoleic esters. J. Biol. Chem., 283, 36624-36635.
7. Rajpopat, S., Moss, C., Mellerio, J., Vahlquist, A., Ganemo, A., Hellstrom-Pigg, M., Ilchyshyn, A., Burrows, N., Lestringant, G., Taylor, A. et al. (2011) Harlequin ichthyosis: a review of clinical and molecular findings in 45 cases. Arch. Dermatol., 147, 681-686.
8. Dyer, J.A., Spraker, M. and Williams, M. (2013) Care of the newborn with ichthyosis. Dermatol. Ther., 26, 1-15.
9. Yanagi, T., Akiyama, M., Nishihara, H., Ishikawa, J., Sakai, K., Miyamura, Y., Naoe, A., Kitahara, T., Tanaka, S. and Shimizu, H. (2010) Self-improvement of keratinocyte differentiation defects during skin maturation in ABCA12-deficient harlequin ichthyosis model mice. Am. J. Clin. Pathol., 177, 106-118.
10. O'Shaughnessy, R.F., Choudhary, I. and Harper, J.I. (2010) Interleukin-1 alpha blockade prevents hyperkeratosis in an in vitro model of lamellar ichthyosis. Hum. Mol. Genet., 19, 2594-2605.
11. Pastore, S., Mascia, F., Gulinelli, S., Forchap, S., Dattilo, C., Adinolfi, E., Girolomoni, G., Di Virgilio, F. and Ferrari, D. (2007) Stimulation of purinergic receptors modulates chemokine expression in human keratinocytes. J. Invest. Dermatol., 127, 660-667.
12. Wang, B., Amerio, P. and Sauder, D.N. (1999) Role of cytokines in epidermal Langerhans cell migration. J. Leukocyte Biol., 66, 33-39.
13. Schafer, M., Farwanah, H., Willrodt, A.H., Huebner, A.J., Sandhoff, K., Roop, D., Hohl, D., Bloch, W. and Werner, S. (2012) Nrf2 links epidermal barrier function with antioxidant defense. EMBO Mol. Med., 4, 364-379.
14. Strachan, L., Murison, J.G., Prestidge, R.L., Sleeman, M.A., Watson, J.D. and Kumble, K.D. (2001) Cloning and biological activity of epigen, a novel member of the epidermal growth factor superfamily. J. Biol. Chem., 276, 18265-18271.
15. Jiang, C.K., Magnaldo, T., Ohtsuki, M., Freedberg, I.M., Bernerd, F. and Blumenberg, M. (1993) Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferationassociated keratins 6 and 16. Proc. Natl. Acad. Sci. USA, 90, 6786-6790.
16. Presland, R.B., Rothnagel, J.A. and Lawrence, O.T. (2006) Feingold, P. M. Elias and K. M. Feingold (ed), In Skin Barrier. Taylor&Francis, New York, pp. 111-140.
17. Hohl, D., de Viragh, P.A., Amiguet-Barras, F., Gibbs, S., Backendorf, C. and Huber, M. (1995) The small proline-rich proteins constitute a multigene family of differentially regulated cornified cell envelope precursor proteins. J. Invest. Dermatol., 104, 902-909.
18. Vermeij, W.P., Alia, A. and Backendorf, C. (2011) ROS quenching potential of the epidermal cornified cell envelope. J. Invest. Dermatol., 131, 1435-1441.
19. Marshall, D., Hardman, M.J., Nield, K.M. and Byrne, C. (2001) Differentially expressed late constituents of the epidermal cornified envelope. Proc. Natl. Acad. Sci. USA, 98, 13031-13036.
20. Smits, P., Poumay, Y., Karperien, M., Tylzanowski, P., Wauters, J., Huylebroeck, D., Ponec, M. and Merregaert, J. (2000) Differentiationdependent alternative splicing and expression of the extracellular matrix protein 1 gene in human keratinocytes. J. Invest. Dermatol., 114, 718-724.
21. Molotkov, A., Fan, X. and Duester, G. (2002) Excessive vitamin Atoxicity in mice genetically deficient in either alcohol dehydrogenase Adh1 or Adh3. Eur. J. Biochem., 269, 2607-2612.
22. Elias, P.M. (1986) Epidermal effects of retinoids: supramolecular observations and clinical implications. J. Am. Acad. Dermatol., 15, 797-809.
23. Beissbarth, T. and Speed, T.P. (2004) GOstat: find statistically overrepresented Gene Ontologies within a group of genes. Bioinformatics, 20, 1464-1465.
24. Segre, J.A. (2006) Epidermal barrier formation and recovery in skin disorders. J. Clin. Invest., 116, 1150-1158.
25. Wiesner, J. and Vilcinskas, A. (2010) Antimicrobial peptides: the ancient arm of the human immune system. Virulence, 1, 440-464.
26. Pazyar, N., Feily, A. and Yaghoobi, R. (2012) An overview of interleukin-1 receptor antagonist, anakinra, in the treatment of cutaneous diseases. Curr. Clin. Pharm., 7, 271-275.
27. Mohamadzadeh, M., Poltorak, A.N., Bergstressor, P.R., Beutler, B. and Takashima, A. (1996) Dendritic cells produce macrophage inflammatory protein-1 gamma, a new member of the CC chemokine family. J. Immunol., 156, 3102-3106.
28. Menzies-Gow, A., Ying, S., Sabroe, I., Stubbs, V.L., Soler, D., Williams, T.J. and Kay, A.B. (2002) Eotaxin (CCL11) and eotaxin-2 (CCL24) induce recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions following cutaneous injection in human atopic and nonatopic volunteers. J. Immunol., 169, 2712-2718.
29. Tettelbach, W., Nanney, L., Ellis, D., King, L. and Richmond, A. (1993) Localization of MGSA/GRO protein in cutaneous lesions. J. Cutan. Pathol., 20, 259-266.
30. Woehrl, B., Klein, M., Rupprecht, T., Schmetzer, H., Angele, B., Hacker, H., Hacker, G., Pfister, H.W. and Koedel, U. (2010) CXCL16 contributes to neutrophil recruitment to cerebrospinal fluid in pneumococcal meningitis. J. Infect. Dis., 202, 1389-1396.
31. McNamee, E.N., Masterson, J.C., Jedlicka, P., McManus, M., Grenz, A., Collins, C.B., Nold, M.F., Nold-Petry, C., Bufler, P., Dinarello, C.A. et al. (2011) Interleukin 37 expression protects mice from colitis. Proc. Natl. Acad. Sci. USA, 108, 16711-16716.
32. Nold, M.F., Nold-Petry, C.A., Zepp, J.A., Palmer, B.E., Bufler, P. and Dinarello, C.A. (2010) IL-37 is a fundamental inhibitor of innate immunity. Nat. Immunol., 11, 1014-1022.
33. Amen, N., Mathow, D., Rabionet, M., Sandhoff, R., Langbein, L., Gretz, N., Jackel, C., Grone, H.J. and Jennemann, R. (2013) Differentiation of epidermal keratinocytes is dependent on glucosylceramide:ceramide processing. Hum. Mol. Genet., 22, 4164-4179.
34. Tan, N.S., Michalik, L., Noy, N., Yasmin, R., Pacot, C., Heim, M., Fluhmann, B., Desvergne, B. and Wahli, W. (2001) Critical roles of PPAR beta/delta in keratinocyte response to inflammation. Genes Dev., 15, 3263-3277.
35. Calleja, C., Messaddeq, N., Chapellier, B., Yang, H., Krezel, W., Li, M., Metzger, D., Mascrez, B., Ohta, K., Kagechika, H. et al. (2006) Genetic and pharmacological evidence that a retinoic acid cannot be the RXR-activating ligand in mouse epidermis keratinocytes. Genes Dev., 20, 1525-1538.
36. Hack, K., Reilly, L., Palmer, C., Read, K.D., Norval, S., Kime, R., Booth, K. and Foerster, J. (2012) Skin-targeted inhibition of PPAR beta/delta by selective antagonists to treat PPAR beta/delta-mediated psoriasis-like skin disease in vivo. PLoS ONE, 7, e37097.
37. Collins, C.A. and Watt, F.M. (2008) Dynamic regulation of retinoic acid-binding proteins in developing, adult and neoplastic skin reveals roles for beta-catenin and Notch signalling. Dev. Biol., 324, 55-67.
38. Lopez, J.M., Fernandez, M.A., Pique, M. and Gil, J. (2004) Aspirin-induced apoptosis in jurkat cells is not mediated by peroxisome proliferator-activated receptor delta. Mol. Cell. Biochem., 266, 57-63.
39. Barber, S.A., Detore, G., McNally, R. and Vogel, S.N. (1996) Stimulation of the ceramide pathway partiallymimics lipopolysaccharide-induced responses in murine peritoneal macrophages. Infect. Immun., 64, 3397-3400.
40. Hvid, M., Johansen, C., Deleuran, B., Kemp, K., Deleuran, M. and Vestergaard, C. (2011) Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines--a possible link between reduced skin barrier function and inflammation? Exp. Dermatol., 20, 633-636.
41. Chiang, M.F., Yang, S.Y., Lin, I.Y., Hong, J.B., Lin, S.J., Ying, H.Y., Chen, C.M., Wu, S.Y., Liu, F.T. and Lin, K.I. (2013) Inducible deletion of the Blimp-1 gene in adult epidermis causes granulocyte-dominated chronic skin inflammation in mice. Proc. Natl. Acad. Sci. USA, 110, 6476-6481.
42. Oh, S.T., Schramme, A., Tilgen, W., Gutwein, P. and Reichrath, J. (2009) Overexpression of CXCL16 in lesional psoriatic skin. Dermatoendocrinology, 1, 114-118.
43. Tohyama, M., Sayama, K., Komatsuzawa, H., Hanakawa, Y., Shirakata, Y., Dai, X., Yang, L., Tokumaru, S., Nagai, H., Hirakawa, S. et al. (2007) CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes. Int. Immunol., 19, 1095-1102.
44. Taha, R.A., Minshall, E.M., Leung, D.Y., Boguniewicz, M., Luster, A., Muro, S., Toda, M. and Hamid, Q.A. (2000) Evidence for increased expression of eotaxin and monocyte chemotactic protein-4 in atopic dermatitis. J. Allergy Clin. Immun., 105, 1002-1007.
45. Fujita, H., Inoue, Y., Seto, K., Komitsu, N. and Aihara, M. (2013) Interleukin-37 is elevated in subjects with atopic dermatitis. J. Dermatol. Sci., 69, 173-175.
46. Teng, X., Hu, Z., Wei, X., Wang, Z., Guan, T., Liu, N., Liu, X., Ye, N., Deng, G., Luo, C. et al. (2014) IL-37 ameliorates the inflammatory process in psoriasis by suppressing proinflammatory cytokine production. J. Immunol., 192, 1815-1823.
47. Cottle, D.L., Kretzschmar, K., Schweiger, P.J., Quist, S.R., Gollnick, H.P., Natsuga, K., Aoyagi, S. and Watt, F.M. (2013) c-MYC-induced sebaceous gland differentiation is controlled by an androgen receptor/p53 axis. Cell Rep., 3, 427-441.
48. Talreja, P., Kleene, N.K., Pickens, W.L., Wang, T.F. and Kasting, G.B. (2001) Visualization of the lipid barrier and measurement of lipid pathlength in human stratum corneum. AAPS Pharm Sci., 3, E13.
49. Wiradjaja, F., Cottle, D.L., Jones, L. and Smyth, I. (2013) Regulation of PDGFCsignalling and extracellular matrix composition by FREM1 in mice. Dis. Model. Mech., 6, 1426-1433.
50. Cottle, D.L., McGrath, M.J., Cowling, B.S., Coghill, I.D., Brown, S. and Mitchell, C.A. (2007) FHL3 binds MyoD and negatively regulates myotube formation. J. Cell Sci., 120, 1423-1435.
51. Nold, M.F., Mangan, N.E., Rudloff, I., Cho, S.X., Shariatian, N., Samarasinghe, T.D., Skuza, E.M., Pedersen, J., Veldman, A., Berger, P.J. et al. (2013) Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia. Proc. Natl. Acad. Sci. USA, 110, 14384-14389.
52. Weir, J.M., Wong, G., Barlow, C.K., Greeve, M.A., Kowalczyk, A., Almasy, L., Comuzzie, A.G., Mahaney, M.C., Jowett, J.B., Shaw, J. et al. (2013) Plasma lipid profiling in a large population-based cohort. J. Lipid Res., 54, 2898-2908.